ASP Isotopes subsidiary enters engagement process with UK nuclear regulators

ASP Isotopes (ASPI) announced a regulatory progress update in its initiative to produce High-Assay Low Enriched Uranium, HALEU, in the United Kingdom. The Company’s UK subsidiary, Quantum Leap Energy, has formally commenced early engagement for regulatory pathways with the UK’s regulators on new nuclear projects. Following successful completion of national security due diligence, the Department for Energy Security and Net Zero confirmed QLE Ltd’s eligibility to enter Early Engagement with the Office for Nuclear Regulation, the regulator for the nuclear industry in the United Kingdom. HALEU is required to fuel most advanced modular reactor designs and this development sets ASP Isotopes’ subsidiary, Quantum Leap Energy, on the path to be the first commercial producer of HALEU in the UK.